| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 8.889 | 0 | 53.584 | 14.475 | 0 |
| Total Income - EUR | - | - | - | - | 2.102 | 43.704 | 0 | 53.584 | 14.475 | 0 |
| Total Expenses - EUR | - | - | - | - | 5.503 | 38.519 | 6.686 | 9.397 | 7.050 | 1.240 |
| Gross Profit/Loss - EUR | - | - | - | - | -3.401 | 5.185 | -6.686 | 44.187 | 7.425 | -1.240 |
| Net Profit/Loss - EUR | - | - | - | - | -3.401 | 5.096 | -6.686 | 42.579 | 6.416 | -1.240 |
| Employees | - | - | - | - | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Teoflor & Adyson S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 2.608 | 3.936 | 1.719 | 1.539 | 853 | 481 |
| Current Assets | - | - | - | - | 22.195 | 4.948 | 12 | 38.353 | 8.822 | 4.723 |
| Inventories | - | - | - | - | 15 | 14 | 14 | 14 | 162 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 30.417 | 796 | 751 |
| Cash | - | - | - | - | 22.181 | 4.933 | -2 | 7.922 | 7.865 | 3.972 |
| Shareholders Funds | - | - | - | - | -3.359 | 1.801 | -4.925 | 37.639 | 6.481 | 5.204 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.078 | 7.083 | 6.657 | 2.252 | 3.194 | 0 |
| Income in Advance | - | - | - | - | 26.084 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Teoflor & Adyson S.r.l.